1. Home
  2. RCON vs NVNO Comparison

RCON vs NVNO Comparison

Compare RCON & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCON
  • NVNO
  • Stock Information
  • Founded
  • RCON 2007
  • NVNO 1987
  • Country
  • RCON China
  • NVNO United States
  • Employees
  • RCON N/A
  • NVNO N/A
  • Industry
  • RCON Oilfield Services/Equipment
  • NVNO Medical/Dental Instruments
  • Sector
  • RCON Energy
  • NVNO Health Care
  • Exchange
  • RCON Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • RCON 60.5M
  • NVNO 71.0M
  • IPO Year
  • RCON 2009
  • NVNO N/A
  • Fundamental
  • Price
  • RCON $2.40
  • NVNO $4.10
  • Analyst Decision
  • RCON
  • NVNO
  • Analyst Count
  • RCON 0
  • NVNO 0
  • Target Price
  • RCON N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • RCON 293.8K
  • NVNO 145.2K
  • Earning Date
  • RCON 07-15-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • RCON N/A
  • NVNO N/A
  • EPS Growth
  • RCON N/A
  • NVNO N/A
  • EPS
  • RCON N/A
  • NVNO N/A
  • Revenue
  • RCON $8,996,572.00
  • NVNO N/A
  • Revenue This Year
  • RCON N/A
  • NVNO N/A
  • Revenue Next Year
  • RCON $12.17
  • NVNO N/A
  • P/E Ratio
  • RCON N/A
  • NVNO N/A
  • Revenue Growth
  • RCON N/A
  • NVNO N/A
  • 52 Week Low
  • RCON $1.35
  • NVNO $2.03
  • 52 Week High
  • RCON $3.70
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • RCON 51.61
  • NVNO 51.11
  • Support Level
  • RCON $2.38
  • NVNO $3.90
  • Resistance Level
  • RCON $2.75
  • NVNO $4.06
  • Average True Range (ATR)
  • RCON 0.32
  • NVNO 0.26
  • MACD
  • RCON -0.02
  • NVNO -0.06
  • Stochastic Oscillator
  • RCON 44.44
  • NVNO 19.61

About RCON Recon Technology Ltd.

Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: